Chimerix Inc (CMRX)
0.9068
-0.01
(-0.76%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
0.00 (0.00%)
After-Hours: 16:25
Chimerix Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 98.98% |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | -660.0% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-660.0%
Minimum
Mar 2022
98.98%
Maximum
Sep 2022
-280.5%
Average
-280.5%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 56.80% |
| SIGA Technologies Inc | 53.59% |
| Tonix Pharmaceuticals Holding Corp | 44.90% |
| Geovax Labs Inc | -- |
| Lyell Immunopharma Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.22% |
| Return on Assets | -43.12% |
| Return on Invested Capital | -48.21% |
| Profit Margin (Quarterly) | -88.00K% |
| Operating Margin (Quarterly) | -95.36K% |
| Return on Net Operating Assets | -3.56K% |